Unknown PHASE4 INTERVENTIONAL 2-arm NCT04864717

Doxycycline vs Isotretinoin for Acneiform Eruptions of TKI

A Randomized Control Trial to Compare Doxycycline to Isotretinoin for the Treatment of Acneiform Eruptions in Cancer Patients on Tyrosine Kinase Inhibitors

Sponsor: Lady Davis Institute

Conditions Acneiform Eruptions Cancer, Treatment-Related

Interventions Doxycycline 100mg po once daily x 6 months Isotretinoin 40 mg po once daily x 6 months

Updated 6 times since 2021 Last updated: Aug 31, 2021 Started: Sep 1, 2021 Primary completion: Dec 31, 2022 Completion: Dec 31, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Acneiform Eruptions and Cancer, Treatment-Related, this trial is ongoing. The trial is conducted by Lady Davis Institute and has accumulated 6 data snapshots since 2021. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Sep 2023 — Jul 2024 [monthly]

Unknown Status PHASE4

Status: Recruiting → Unknown Status
Oct 2021 — Sep 2023 [monthly]

Recruiting PHASE4

Status: Not Yet Recruiting → Recruiting
Jun 2021 — Oct 2021 [monthly]

Not Yet Recruiting PHASE4

▶ Show 1 earlier version

May 2021 — Jun 2021 [monthly]

Not Yet Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Lady Davis Institute

Data source: Lady Davis Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Montreal, Canada